s100a8 - OmicsDI

Show results for

Unknown (995)
Transcriptomics (253)
Genomics (229)
Proteomics (68)
Other (4)
Methylation profiling (3)
Metabolomics (3)

Organisms

Mus musculus (131)
Homo sapiens (126)
Andropogon gerardi (44)
Bacteria (44)
Canis lupus familiaris (44)
Clostridium perfringens (44)
Cnidaria (44)
Cricetulus griseus (44)
Eukaryota (44)
Fasciola (44)
Hepatitis B virus (44)
Human betaherpesvirus 5 (44)
Japanese encephalitis virus group (44)
Madurella mycetomatis (44)
Mesocricetus auratus (44)
Miscanthus x giganteus (44)
Rattus norvegicus (13)
Rhizobium leguminosarum (4)
Helicobacter pylori (4)
Sus scrofa (3)
Bos taurus (2)
Staphylococcus aureus subsp. aureus str. Newman (1)
Streptococcus agalactiae (1)
Schistosoma japonicum (1)
Campylobacter jejuni (1)
feces metagenome (1)
Oryctolagus cuniculus (1)
Macaca mulatta (1)
Macaca fascicularis fascicularis (1)
human blood metagenome (1)

Organisms

Mus musculus (91)
Homo sapiens (74)
Rattus norvegicus (6)
Sus scrofa (2)
Bos taurus (2)
Campylobacter jejuni (1)
Mus sp. (1)
feces metagenome (1)

Repository

ENA (219)
geo (177)
biostudies-arrayexpress (91)
pride (44)
iProX (15)
MassIVE (5)
EGA (3)
MetaboLights (3)
PanoramaPublic (2)
PAXDB (1)

Tissue

Blood plasma (7)
Cell culture (4)
Colon (4)
Blood (3)
Feces (3)
Blood platelet (2)
Blood serum (2)
Carotid artery (2)
Ileum (2)
Neutrophil (2)
Pancreas (2)
Platelet (2)
Saliva (2)
Skin (2)
Aorta (1)
Biofilm (1)
Blood cell (1)
Bone marrow (1)
Cerebrospinal fluid (1)
Culture fluid (1)
Erythroblast (1)
Head and neck squamous cell carcinoma cell (1)
Heart (1)
Kidney (1)
Leukocyte (1)
Lung (1)
Megakaryocyte progenitor cell (1)
Melanocyte (1)
Osteoclast (1)
Preosteoclast (1)

Disease

Normal (3)
Cardiovascular system disease (3)
Crohn's disease (2)
Inflammatory bowel disease (2)
Ulcerative colitis (2)
HIV-associated dementia (1)
Alcohol-associated liver disease (1)
Atherosclerosis (1)
Brain glioblastoma multiforme (1)
Central retinal vein occlusion (1)
Cerebral malaria (1)
Diabetes mellitus (1)
Gastrointestinal system disease (1)
Melanoma (1)
Myocardial ischemia (1)
Pancreatic cancer (1)
Pre-eclampsia (1)
Salivary gland disease (1)
Streptococcal meningitis (1)

Technology Type

Mass Spectrometry (44)
Shotgun proteomics (19)
Bottom-up proteomics (17)
Data-dependent acquisition (6)
Data-independent acquisition (4)
Mass spectrometry (3)
Gel-based experiment (3)
Illumina HiSeq 2500, ILLUMINA (1)
DiaPASEF (1)
MSE (1)
Proteogenomics (1)
SRM/MRM (1)
Top-down proteomics (1)

Instrument Platform

Q Exactive (4)
Illumina HiSeq 2000 (2)
NextSeq 500 (2)
Liquid Chromatography MS - negative - reverse phase (2)
NextSeq 550 (Illumina). (1)
Illumina NovaSeq X (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
Illumina NovaSeq 6000 (1)
LTQ Orbitrap Velos (1)
Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (44)
2023 (41)
2026 (36)
2022 (20)
2020 (19)
2024 (18)
2015 (15)
2011 (15)
2010 (15)
2016 (14)
2013 (13)
2021 (13)
2014 (9)
2012 (9)
2009 (9)
2005 (9)
2008 (8)
2019 (8)
2017 (8)
2018 (4)
2007 (1)
2004 (1)

UNIPROT ID/AC

89462.XP_006039905.1 (1)
89462.XP_006039931.1 (1)
89462.XP_006040040.1 (1)
89462.XP_006040190.1 (1)
89462.XP_006040234.1 (1)
89462.XP_006040835.1 (1)
89462.XP_006041112.1 (1)
89462.XP_006041162.1 (1)
89462.XP_006041532.1 (1)
89462.XP_006041551.1 (1)
89462.XP_006041590.1 (1)
89462.XP_006041720.1 (1)
89462.XP_006041937.1 (1)
89462.XP_006041942.1 (1)
89462.XP_006042163.1 (1)
89462.XP_006042170.1 (1)
89462.XP_006042246.1 (1)
89462.XP_006042337.1 (1)
89462.XP_006042595.1 (1)
89462.XP_006042626.1 (1)
89462.XP_006042699.1 (1)
89462.XP_006042855.1 (1)
89462.XP_006042907.1 (1)
89462.XP_006043002.1 (1)
89462.XP_006043089.1 (1)
89462.XP_006043189.1 (1)
89462.XP_006043252.1 (1)
89462.XP_006043256.1 (1)
89462.XP_006043264.1 (1)
89462.XP_006043557.1 (1)

CHEBI ID

CHEBI:46659 (2)
CHEBI:45980 (2)
CHEBI:34690 (2)
CHEBI:27402 (2)
CHEBI:16805 (2)
CHEBI:9093 (2)
CHEBI:7494 (2)
CHEBI:3746 (2)
CHEBI:3219 (2)
CHEBI:3077 (2)
CHEBI:177282 (2)
CHEBI:80127 (2)
CHEBI:7856 (2)
CHEBI:17401 (2)
CHEBI:10049 (2)
CHEBI:27836 (2)
CHEBI:8497 (2)
CHEBI:16019 (2)
CHEBI:9352 (2)
CHEBI:28748 (2)
CHEBI:28866 (2)
CHEBI:31648 (2)
CHEBI:2453 (2)
CHEBI:5557 (2)
CHEBI:16871 (2)
CHEBI:10444 (2)
CHEBI:168124 (2)
CHEBI:9342 (2)
CHEBI:10082 (2)
CHEBI:27701 (2)

Metabolite Name

Laurylaldehyde (2)
(S)-3-Hydroxyhexadecanoyl-CoA (2)
Undecan-2-one (2)
Clindamycin phosphate (2)
Bupropion (2)
Myo-inositol hexakisphosphate (2)
Haloperidol (2)
Beta-D-3-Ribofuranosyluric acid (2)
5-Methyltetrahydrofolic acid (2)
Cyclic GMP (2)
Oxytetracycline (2)
Xanthosine 5-triphosphate (2)
Cyanidin 3-glucoside (2)
Sulindac (2)
Sinensal (2)
Prenol (2)
2-Methoxy-estradiol-17b 3-glucuronide (2)
Thiamine monophosphate (2)
Tetracosanoic acid (2)
Neryl formate (2)
Aciclovir (2)
Guanethidine (2)
Pentadecanal (2)
Sulfinpyrazone (2)
Ibutilide (2)
Nicardipine (2)
Agmatine (2)
Butanal (2)
Cysteic acid (2)
Ipratropium bromide (2)

First Public Date

2025 (40)
2024 (33)
2026 (28)
2023 (28)
2020 (18)
2014 (16)
2022 (15)
2021 (15)
2017 (6)
2019 (5)
2018 (5)
2015 (4)
2016 (3)
2013 (3)

Classification

bacteria (1)

Study type

Transcription profiling by array (69)
Transcription profiling by RT-PCR (6)
RNA-seq of coding RNA (5)
Unknown experiment type (3)
RNA-seq of coding RNA from single cells (3)
Comparative genomic hybridization by array (2)
Transcription profiling by SAGE (1)
DNA-seq (1)
Proteomic profiling by array (1)

Release Date

2025 (129)
2022 (129)
2023 (126)
2021 (114)
2024 (102)
2020 (69)
2015 (48)
2019 (45)
2017 (41)
2018 (40)
2016 (39)
2013 (31)
2014 (29)
2011 (27)
2010 (27)
2026 (22)
2012 (22)
2009 (21)
2008 (11)
2005 (10)
2006 (3)
2007 (1)

Lab affiliation

Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; Department of Physiology and Pharmacology, University of Calgary, Alberta, Canada; The Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Alberta, Canada (2)
Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel (2)
King's College London, British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK (2)
Sichuan University (2)
1. INSERM U1287, Université Paris-Saclay, Gustave Roussy Cancer Center, Villejuif, France 2. Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France (1)
Baker Heart and Diabetes Institute, Aus (1)
Bioanalytical Research Labs, Department of Biosciences, University of Salzburg (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands and Netherlands Proteomics Center, Utrecht, The Netherlands (1)
Boston College, Chemistry (1)
Centre for Proteome Research, University of Liverpool (1)
Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Univer-sidade de Lisboa, Portugal (1)
China-Japan Union Hospital of Jilin University (1)
Consultant Medical oncology (1)
Department of Anatomy and Developmental BiologyMonash University, Clayton, Victoria, Australia; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. Alexander N Combes alex.combes@monash.edu. David J Nikolic-Paterson david.nikolic-paterson@monash.edu. (1)
Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Poland (1)
Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland (1)
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX (1)
Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada. McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada. (1)
Department of Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
Guangxi Medical University (1)
Head of Mass Spectrometry Laboratory, Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP, Brazil. (1)
Institute of Biomedical Chemistry, 119121 Moscow, 10 Pogodinskaya str., bld. 8, Russian Federation; tel.: +7 495 246 16 41; web: www.ibmc.msk.ru (1)
Institute of Cellular Biology and Pathology "N. Simionescu", Proteomics Department, Bucharest, Romania (1)
Institute of Cellular Biology and Pathology "Nicolae Simionescu" (1)
Institute of Medical Biochemistry, Protein Core Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria (1)
Institute of Reproductive Health, Tong Ji Medical College, Hua Zhong University of Science and Technology, Wuhan, China. (1)
Keck MS & Proteomics Resource at Yale School of Medicine (1)
King's BHF Centre, King's College London, London, UK (1)
King's British Heart Foundation Centre, King's College London, London, United Kingdom (1)
Laboratory for Structural and Computational Proteomics, Carlos Chagas Institute, Fiocruz–PR, Brazil. (1)

Previous page
1 / 156
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 156
Next page

Sort by:

Relevance

Page size

S100A8/A9 activate key genes and pathways in colon tumor progression

Studies using bone marrow chimeric mice revealed that S100A8/A9 expression on myeloid cells is essential for development of colon tumors. Our results thus reveal a novel role for myeloid-derived S100A8/A9 in activating specific downstream genes associated with tumorigenesis and in promoting tumor gr...

ORGANISM(S): Mus musculus

2011-02-01 | E-GEOD-26359 | biostudies-arrayexpress

S100A8 treatment on gene expression of human umbilical vascular endothelial cells.

Previous studies showed that S100A8 and S100A9 are involved in neovascularization as well as in tumor development. At high concentrations, S100A8 and S100A9 cause inflammatory response or apoptosis mediated damage in vascular endothelial cells. But the effect of low concentrations of such proteins o...

ORGANISM(S): Homo sapiens

2011-11-20 | E-GEOD-33768 | biostudies-arrayexpress

Fecal detection of calprotectin subunits links IBD activity with chronicity of intestinal inflammation.

Quantification of the human S100A8/S100A9 tetrameric protein complex in stool, referred to as fecal calprotectin, is an extensively validated biomarker supporting the diagnosis and management of gastrointestinal diseases1,2. The quaternary protein structures (called configuration here) of S100A8 and...

ORGANISM(S): Homo sapiens (Human)

2025-12-18 | PXD068250 | Pride

Real-time quantitative PCR analysis of mice lung tissue (2)

Recombinant-murine S100A8 and the corresponding Cys42 to Ala42 mutant were used at 10 mg/50 ml HBSS administered onto the nares of BALB/C mice. To assess direct effects, mice were sacrificed 1, 4, 6, 12 or 20 h post-inhalation of S100A8 or 12 and 20 h post-inhalation of Ala42S100A8. For comparison w...

ORGANISM(S): Mus musculus

2013-11-26 | E-GEOD-52719 | biostudies-arrayexpress

Real-time quantitative PCR analysis of mice lung tissue (1)

ORGANISM(S): Mus musculus

2013-11-26 | E-GEOD-52718 | biostudies-arrayexpress

Biological effects of recombinant S100A8, recombinant S100A9, and recombinant S100A8/S100A9 on human renal tubular epithelial cells (HK-2)

PRJNA1104534 | ENA

Transcription profiling of esophageal squamous cells from rats fed different diets with zinc replenishment

We report that Zinc Replenishment Reverses Overexpression of the Proinflammatory Mediator S100A8 and Esophageal Preneoplasia in the Rat

ORGANISM(S): Rattus norvegicus

2009-05-28 | E-TABM-501 | biostudies-arrayexpress

S100A8/S100A9 cytokine functions as transcriptional coactivator during breast cellular transformation

PRJNA649704 | ENA

New Insights into the impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8

Human Papillomavirus (HPV) infection has been recently linked to a subset of cancers affecting the oral cavity. However, the molecular mechanisms underlying HPV-driven oral squamous cell carcinoma (OSCC) onset and/ progression are poorly understood. Methods: We perform a MS-based proteomic profiling...

ORGANISM(S): Homo sapiens (Human)

2023-07-20 | PXD041856 | Pride

New insights into the impact of human papillomavirus on oral cancer in young patients: proteomic approach reveals a novel role for s100a8

Effects of S100A8 inhalation on expression of genes in the lung microenvironment

PRJNA788521 | ENA

Previous page
1 / 156
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 156
Next page

Sort by:

Relevance

Page size

1555 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets